These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36893704)

  • 21. Post-Embolization Syndrome Complicated by Hypertensive Emergency and Severely Elevated Transaminases.
    Kashfi S; Murdakhayev E; Rehmani R; Sharma S
    Cureus; 2021 Jun; 13(6):e15446. PubMed ID: 34258113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complications of transarterial chemoembolization (TACE) in the treatment of liver tumors.
    Marcacuzco Quinto A; Nutu OA; San Román Manso R; Justo Alonso I; Calvo Pulido J; Manrique Municio A; García-Sesma Á; Loinaz Segurola C; Martínez Caballero J; Jiménez Romero LC
    Cir Esp (Engl Ed); 2018 Nov; 96(9):560-567. PubMed ID: 30082086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of perfusion reduction by using 2D-perfusion angiography following transarterial chemoembolization with drug-eluting beads.
    Maschke SK; Werncke T; Klöckner R; Rodt T; Renne J; Kirstein MM; Vogel A; Wacker FK; Meyer BC; Hinrichs JB
    Abdom Radiol (NY); 2018 May; 43(5):1245-1253. PubMed ID: 28840307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rare case of gastric perforation by a 5-year-old Intra-gastric Balloon in situ: Case report and review of literature.
    Vinod VC; Younis MU; Mubarik H; Rivas H
    Int J Surg Case Rep; 2020; 76():480-483. PubMed ID: 33207414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed intratumoral hemorrhage after drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma.
    Shiozawa K; Watanabe M; Ikehara T; Ogino Y; Umakoshi T; Matsukiyo Y; Kogame M; Matsui T; Kikuchi Y; Igarashi Y; Sumino Y
    Case Rep Oncol; 2014 Sep; 7(3):739-45. PubMed ID: 25520649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer.
    Xia J; Ren Z; Ye S; Sharma D; Lin Z; Gan Y; Chen Y; Ge N; Ma Z; Wu Z; Fan J; Qin L; Zhou X; Tang Z; Yang B
    Eur J Radiol; 2006 Sep; 59(3):407-12. PubMed ID: 16621394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spontaneous hepaticoduodenal and choledochoduodenal fistula mimicking duodenal ulcer perforation, a very rare complication of transarterial chemoembolization.
    Prachayakul V; Aswakul P
    Case Rep Gastroenterol; 2015; 9(1):68-73. PubMed ID: 25873850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of drug-eluting bead transarterial chemoembolization loaded with cisplatin on normal dogs.
    Nakasumi K; Yamamoto N; Takami T; Itoh H; Itamoto K; Horikirizono H; Iseri T; Nakaichi M; Nemoto Y; Sunahara H; Tani K
    J Vet Med Sci; 2022 Jan; 84(1):114-120. PubMed ID: 34866073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of ruptured hepatocellular carcinoma invading the gastrointestinal tract: A case report.
    Hafez B; Osman B; Chami J; Ahmad JH; Ataya K; Khalife MJ
    Int J Surg Case Rep; 2022 Jul; 96():107330. PubMed ID: 35810682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreas lipiodol embolism induced acute necrotizing pancreatitis following transcatheter arterial chemoembolization for hepatocellular carcinoma: A case report and literature review.
    Tan Y; Sheng J; Tan H; Mao J
    Medicine (Baltimore); 2019 Nov; 98(48):e18095. PubMed ID: 31770228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
    Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of transarterial chemoembolization in Egyptian patients with hepatocellular carcinoma and branch portal vein thrombosis.
    Abdella H; Shaker MK; Montasser IF; Sobhi M; Aly H; Sayed A; Saleh S; El Dorry A
    Indian J Gastroenterol; 2018 Mar; 37(2):127-132. PubMed ID: 29532323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimally invasive percutaneous endovascular therapies in the management of complications of non-alcoholic fatty liver disease (NAFLD): A case report.
    Salsamendi J; Pereira K; Kang K; Fan J
    J Radiol Case Rep; 2015 Sep; 9(9):36-43. PubMed ID: 26629307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of radiofrequency ablation following transarterial chemoembolisation combined with sorafenib for intermediate stage recurrent hepatocellular carcinoma: a retrospective, multicentre, cohort study.
    Wang XH; Duan WB; Liang W; Li H; Xie XY; Li SQ; Chen MS; Liang P; Mao XH; Zhou QF
    EClinicalMedicine; 2023 Feb; 56():101816. PubMed ID: 36703645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ruptured hepatic carcinoma after transcatheter arterial chemoembolization.
    Jia Z; Tian F; Jiang G
    Curr Ther Res Clin Exp; 2013 Jun; 74():41-3. PubMed ID: 24384870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
    Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
    Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model.
    Qian J; Oppermann E; Tran A; Imlau U; Qian K; Vogl TJ
    World J Gastroenterol; 2016 Jun; 22(21):5042-9. PubMed ID: 27275096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma: A Multicenter, Randomized Controlled Trial.
    Zheng DH; Yang JM; Wu JX; Cheng SQ; Zhang SG; Wu D; Li AJ; Fu XH; Li X; Qi FC; Duan WH; Chen JH; Yang ZY; Liang L; Zeng JX; Zheng WD; Wu MC
    Chin J Integr Med; 2023 Jan; 29(1):3-9. PubMed ID: 35915317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
    Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
    Trials; 2012 Aug; 13():144. PubMed ID: 22913492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid Intrahepatic Progression of Hepatocellular Carcinoma after Transarterial Chemoembolization: A Case Report.
    Siraj TH; Tameez Ud Din A; Chaudhary FMD; Ahmad S; Siddiqui KH
    Cureus; 2019 Aug; 11(8):e5305. PubMed ID: 31592085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.